Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
140.34
+2.35 (1.70%)
At close: Aug 31, 2026, 4:00 PM EDT
138.74
-1.60 (-1.14%)
After-hours: Aug 31, 2026, 7:59 PM EDT
Moderna Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,228 | 1,944 | 3,236 | 6,848 | 19,263 | 18,471 |
Revenue Growth | -27.62% | -39.93% | -52.74% | -64.45% | 4.29% | 2200.25% |
Gross Profit Gross Profit Growth | -1,471 | -2,056 | -2,771 | -2,690 | 10,552 | 13,863 |
Operating Income Operating Income Growth | -2,436 | -3,074 | -3,945 | -4,239 | 9,420 | 13,296 |
Net Income Net Income Growth | -3,151 | -2,822 | -3,561 | -4,714 | 8,362 | 12,202 |
Earnings Per Share EPS Growth | -8.01 | -7.25 | -9.27 | -12.34 | 20.12 | 28.29 |
EPS Growth | - | - | - | - | -28.88% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Product Sales Product Sales Growth | 2,064 | 1,818 | 3,109 | 6,671 | 18,435 | 17,675 |
Grant Grant Growth | - | 22 | 37 | 94 | 388 | 735 |
Collaboration Collaboration Growth | 28 | 13 | 48 | 83 | 440 | 61 |
Licensing and Royalty Licensing and Royalty Growth | - | 11 | 42 | - | - | - |
Stand-Ready Manufacturing Stand-Ready Manufacturing Growth | 114 | 80 | - | - | - | - |
Revenue (Total) Revenue (Total) Growth | 2,228 | 1,944 | 3,236 | 6,848 | 19,263 | 18,471 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 6,910 | 8,135 | 9,519 | 13,281 | 18,220 | 17,570 |
Total Debt Total Debt Growth | 1,287 | 1,305 | 747 | 1,243 | 1,200 | 916 |
Net Cash (Debt) Net Cash Growth | 5,623 | 6,830 | 8,772 | 12,038 | 17,020 | 16,654 |
Net Cash Growth | -16.87% | -22.14% | -27.13% | -29.27% | 2.20% | 232.41% |
Net Cash Per Share Net Cash Per Share Growth | 14.29 | 17.56 | 22.84 | 31.51 | 40.91 | 38.64 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -1,073 | -1,873 | -3,004 | -3,118 | 4,981 | 13,620 |
Capital Expenditures CapEx Growth | -171 | -192 | -1,051 | -707 | -400 | -284 |
Free Cash Flow Free Cash Flow Growth | -1,244 | -2,065 | -4,055 | -3,825 | 4,581 | 13,336 |
Free Cash Flow Growth | - | - | - | - | -65.65% | 580.75% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -66.02% | -105.76% | -85.63% | -39.28% | 54.78% | 75.05% |
Operating Margin | -109.34% | -158.13% | -121.91% | -61.90% | 48.90% | 71.98% |
Pretax Margin | -138.55% | -142.39% | -111.46% | -57.56% | 49.71% | 71.92% |
Profit Margin | -141.43% | -145.17% | -110.04% | -68.84% | 43.41% | 66.06% |
FCF Margin | -55.84% | -106.22% | -125.31% | -55.86% | 23.78% | 72.20% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 8.25 | 8.44 |
Forward PE | - | 31.94 | 31.94 | 31.94 | 37.04 | 8.08 |
P/FCF Ratio | - | - | - | - | 15.06 | 7.72 |
PS Ratio | 25.15 | 5.93 | 4.95 | 5.54 | 3.58 | 5.58 |